Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.68 |
| ▸ | SHBG | P04278 | 1/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.68 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.56 |
| ▸ | PGR | P06401 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17302789 | 1.00 | MAPT (0.71) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL13177160 | 1.00 | MAPT (0.71) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL2930366 | 1.00 | MAPT (0.71) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL3458086 | 0.91 | MAPT (0.71) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL24103254 | 0.90 | MAPT (0.69) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL9473555 | 0.90 | MAPT (0.69) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL6445859 | 0.90 | MAPT (0.69) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL24103304 | 0.90 | MAPT (0.69) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL21067996 | 0.89 | MAPT (0.84) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL343128 | 0.88 | MAPT (0.79) | MAPTLMNASERPINA6ALDH1A1SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2054540-B1 | TAGGING REAGENTS AND METHODS FOR HYDROXYLATED COMPOUNDS | DH TECHNOLOGIES DEV PTE LTD (SG) | 2014-11-26 | — | — | EP | disclosed |
| WO-2009074313-A1 | METHOD FOR THE AROMATIZATION OF 19-NOR-ANDROST-4-EN-3-ONES INTO ESTRA-1,3,5(10)-TRIENES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-06-18 | — | — | WO | disclosed |
| US-20090156843-A1 | PROCESS FOR AROMATIZING 19-NORANDROST-4-EN-3-ONES TO ESTRA-1,3,5(10)-TRIENES | BAYER SCHERING PHARMA AG (DE) | 2009-06-18 | — | — | US | disclosed |
| US-20090156843-A1 | PROCESS FOR AROMATIZING 19-NORANDROST-4-EN-3-ONES TO ESTRA-1,3,5(10)-TRIENES | BAYER SCHERING PHARMA AG (DE) | 2009-06-18 | — | — | US | disclosed |
| EP-2070942-A1 | Method for aromatising 19-nor-androst-4-en-3-ones to estra-1,3,5(10)-trienes | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-06-17 | — | — | EP | disclosed |
| EP-1918295-A2 | Process and Intermediates | AstraZeneca AB (SE) | 2008-05-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156843-A1 | PROCESS FOR AROMATIZING 19-NORANDROST-4-EN-3-ONES TO ESTRA-1,3,5(10)-TRIENES | CYP19A1, HSD17B11, NR5A1 | MAPT 3108/4885LMNA 3194/4885SERPINA6 991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.